1350751-89-1

Upstream product

• 106-49-0 p-toluidine 
• 119-53-9 2-hydroxy-2-phenylacetophenone 
• 64-18-6 formic acid 
• 1350751-87-9 2-amino-1-(4-methylphenyl)-4,5-diphenyl-1H-pyrrole-3-carbonitrile 

Downstream Products

• 1350751-91-5 7-(4-methylphenyl)-5,6-diphenyl-7H-pyrrolo[2,3-d]pyrimidin-4(3H)-thione 
• 1350751-93-7 (7-(4-methylphenyl)-5,6-diphenyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-hydrazine 
• 1350751-95-9 7-(4-methylphenyl)-8,9-diphenyl-7H-pyrrolo[3,2-e][1,2,4]triazolo[4,3-c]pyrimidine-3-thione 
• 1350751-96-0 7-(4-methylphenyl)-8,9-diphenyl-7H-pyrrolo[3,2-e][1,2,4]triazolo[4,3-c]pyrimidine 
• 1350751-97-1 3-methyl-7-(4-methylphenyl)-8,9-diphenyl-7H-pyrrolo[3,2-e][1,2,4]triazolo[4,3-c]pyrimidine 
• 1350751-94-8 N-benzylidene-N'-(7-(4-methylphenyl)-5,6-diphenyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-hydrazine 
• 1350751-90-4 4-chloro-7-(4-methylphenyl)-5,6-diphenyl-7H-pyrrolo[2,3-d]pyrimidine 

Relevant academic research and scientific papers

Synthesis and kinetic testing of new inhibitors for a metallo-β- lactamase from Klebsiella pneumonia and Pseudomonas aeruginosa

There are currently no clinically useful inhibitors against metallo-β-lactamases (MBLs), enzymes that confer resistance against a broad spectrum of commonly used antibiotics and that are produced by an increasing number of bacterial pathogens. New pyrrole